Similar Items
-
GLP-1 receptor agonists and cardiovascular outcome trials: An update
by: Eirini Andrikou, et al.
Published: (2019-11-01) -
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
by: Kristensen, SL, et al.
Published: (2019) -
An updated perspective and pooled analysis of cardiovascular outcome trials of GLP-1 receptor agonists and SGLT-2 inhibitors
by: Mustafa Kılıçkap, et al.
Published: (2021-02-01) -
Risk of stroke and retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: An eight RCTs meta-analysis
by: Jinjing Wei, et al.
Published: (2022-12-01) -
GLP-1 Receptor Agonists and Kidney Protection
by: Eulalia Valentina Greco, et al.
Published: (2019-05-01)